Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
about
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaLocal Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment.Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.Th17 Cells in Protection from Tumor or Promotion of Tumor ProgressionRedirecting the focus of cancer immunotherapy to premalignant conditions.HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.Role of IL-23 signaling in the progression of premalignant oral lesions to cancer.Th17 response in patients with cervical cancer
P2860
Q26752515-BADFB59E-214A-4C20-BA1B-EA1EF32BEA40Q33832752-8BBD4625-996B-4A46-B0C0-33D20C76AE7EQ37362880-A2002004-679F-4677-A4EB-F07647E7EB07Q38907336-CD0862B5-73C9-4C47-84AE-23E714A5CEE2Q39107022-00D81772-A1F1-451F-90AF-E8FB7D8FD832Q42365249-72D5A740-1378-469A-8E4A-E7D853802EDCQ52719969-147ED96D-170E-4043-AE63-E27DA35FF729Q53109856-09C87ADA-9094-4331-9CB8-CC18006946E1Q55003290-3FD63E35-0BF0-4EEC-9446-8D513E4F259EQ55265890-9B666F76-0EC2-4207-8FAB-D9CE27E3A15CQ58572928-BC3CD314-6CD4-4C5B-9BA7-27E2E895E67F
P2860
Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@en
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@nl
type
label
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@en
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@nl
prefLabel
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@en
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@nl
P2093
P2860
P356
P1476
Treatment to sustain a Th17-ty ...... lesion progression to cancer.
@en
P2093
Corinne A Levingston
M Rita I Young
Sara D Johnson
P2860
P304
P356
10.1002/IJC.29989
P577
2016-01-28T00:00:00Z